Equities

Ondine Biomedical Inc

OBI:LSE

Ondine Biomedical Inc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)9.00
  • Today's Change0.00 / 0.00%
  • Shares traded42.16k
  • 1 Year change-28.00%
  • Beta0.4865
Data delayed at least 20 minutes, as of Feb 06 2026 12:53 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Ondine Biomedical Inc. is a Canadian life sciences company. The Company specializes in light-activated antimicrobial therapies (photo disinfection) for the prevention and treatment of infections, including those caused by multidrug-resistant organisms. The Company has a pipeline of investigational products, based on its proprietary photo disinfection technology, in various stages of development. The Company's nasal photo disinfection system has a CE mark in Europe and is approved in Canada, Australia, Mexico and several other countries under the name Steriwave. In the United States, it has been granted Qualified Infectious Disease Product designation and Fast Track status by the FDA and is undergoing clinical trials for regulatory approval. Its products beyond nasal photo disinfection include therapies for a variety of medical indications such as chronic sinusitis, ventilator-associated pneumonia, serious burns, chronic wounds, central line bloodstream infections and other indications.

  • Revenue in GBP (TTM)1.19m
  • Net income in GBP-12.89m
  • Incorporated1996
  • Employees43.00
  • Location
    Ondine Biomedical Inc888-1100 Melville StVANCOUVER V6E 4A6CanadaCAN
  • Phone+1 60 4669 0555Fax+1 60 4669 0555
  • Websitehttps://ondinebio.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Verici DX PLC1.41m-5.63m10.97m15.0010.97m15.00
Genedrive PLC954.00k-5.23m11.84m43.0011.84m43.00
Cellbxhealth PLC2.62m-15.78m11.96m119.0011.96m119.00
Abingdon Health PLC8.43m-3.42m15.06m121.0015.06m121.00
Inspiration Healthcare Group PLC45.20m-11.44m15.69m214.0015.69m214.00
Renalytix PLC2.22m-15.08m24.47m45.0024.47m45.00
Aptamer Group PLC1.20m-2.42m25.62m31.0025.62m31.00
Aoti Inc47.22m1.74m44.01m80.0044.01m80.00
Ondine Biomedical Inc1.19m-12.89m46.92m43.0046.92m43.00
Inspecs Group PLC192.83m-3.31m69.64m1.65k69.64m1.65k
Creo Medical Group PLC2.20m12.60m72.18m133.0072.18m133.00
SDI Group PLC69.29m4.59m85.75m504.0085.75m504.00
EKF Diagnostics Holdings PLC50.22m6.12m106.26m297.00106.26m297.00
Data as of Feb 06 2026. Currency figures normalised to Ondine Biomedical Inc's reporting currency: UK Pound GBX

Institutional shareholders

26.50%Per cent of shares held by top holders
HolderShares% Held
M&G Investment Management Ltd.as of 03 Sep 202567.25m12.97%
Janus Henderson Investors UK Ltd.as of 30 Jun 202550.27m9.70%
Chelverton Asset Management Ltd.as of 30 Jun 202516.00m3.09%
Premier Fund Managers Ltd.as of 31 Jul 20253.84m0.74%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.